Primary Progressive Aphasia Clinical Trial
Official title:
Transcranial Magnetic Stimulation in Primary Progressive Aphasia
Verified date | May 2020 |
Source | Hospital San Carlos, Madrid |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Primary progressive aphasia (PPA) is a clinical syndrome characterized by the
neurodegeneration of language brain systems. Three main clinical variants are currently
recorgnized (nonfluent, semantic, and logopenic PPA). Nowadays, there are no effective
treatments for this disorder.
Transcranial Magnetic Stimulation (TMS) is a technique based on the principle of
electromagnetic induction of an electric field in the brain. It has been used as a
non-invasive therapy in different disorders, such as depression, bipolar disorder,
Parkinson's disease, and in the rehabilitation of post-stroke aphasia. Recent studies have
shown how repetitive TMS improved language characteristics in Alzheimer's disease, and there
are initial data in patients with PPA.
This research project investigates the effect of repetitive TMS in patients with PPA.
Investigators will perform a personalized TMS treatment for each patient (brain region, type
of stimulation/inhibition, etc.), according to the specific characteristics of each patient
and with the final aim to generate a computational model.
Status | Completed |
Enrollment | 20 |
Est. completion date | March 10, 2020 |
Est. primary completion date | March 10, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years and older |
Eligibility |
Inclusion Criteria: - Must be clinically diagnosed of PPA according to current diagnostic criteria (Gorno-Tempini et al. 2011) with PET-FDG confirmation. - Clinical Dementia Rating 0-1. Exclusion Criteria: - Contraindications for TMS or MRI - History of epilepsy - Pregnancy - Other language disorder previous to the diagnosis of PPA - Neuroimaging not suggestive of PPA |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Clínico San Carlos. | Madrid |
Lead Sponsor | Collaborator |
---|---|
Hospital San Carlos, Madrid | Universidad Complutense de Madrid |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in spontaneous speech (main primary endpoint) | Picture and story description task | 2 months (at baseline and at the end of the treatment) | |
Primary | Changes in oral naming | Object naming test | 2 months | |
Primary | Changes in reading | Story and words reading test | 2 months | |
Primary | Changes in repetition | Non-words and sentence repetition task | 2 months (at baseline and at the end of the treatment) | |
Secondary | Changes in brain metabolism | Brain metabolism measured using 18F-FDG-PET | 2 months (at baseline and at the end of the treatment) | |
Secondary | Changes in clinical impression of change | Patient's clinical impression of change (from 0 to 10) | 2 months (at baseline and at the end of the treatment) | |
Secondary | Changes in brain cortical electrical activity | Changes in the brain cortical electrical activity measured using quantitative electroencephalography (EEG) | 2 months (at baseline and at the end of the treatment) | |
Secondary | Changes in global cognition | Addenbrooke's Cognitive Examination III | 2 months (at baseline and at the end of the study) | |
Secondary | Changes in clinical impression of change | Caregiver's clinical impression of change (from 0 to 10) | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT04290988 -
Circuitry Assessment and Reinforcement Training Effects on Recovery
|
N/A | |
Recruiting |
NCT04957537 -
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
|
N/A | |
Completed |
NCT04045990 -
Network Modulation in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05443633 -
Enhancing Language Function in Aphasia
|
N/A | |
Completed |
NCT05860647 -
Transmagnetic Stimulation Pilot in Primary Progressive Aphasia
|
N/A | |
Recruiting |
NCT03887481 -
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
|
N/A | |
Completed |
NCT03728582 -
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
|
N/A | |
Completed |
NCT01465360 -
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
|
N/A | |
Completed |
NCT02541097 -
Preventing Language Decline in Dementia
|
N/A | |
Recruiting |
NCT00537004 -
Language in Primary Progressive Aphasia
|
||
Recruiting |
NCT05741853 -
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
|
N/A | |
Active, not recruiting |
NCT05742698 -
Nabilone for Agitation in Frontotemporal Dementia
|
Phase 2 | |
Completed |
NCT02439853 -
Communication Bridge Speech Therapy Research Study
|
N/A | |
Completed |
NCT01623284 -
PiB PET Scanning in Speech and Language Based Dementias
|
Phase 1 | |
Completed |
NCT04726527 -
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
|
||
Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
Completed |
NCT05537688 -
Identification of Graphic Markers of Neurocognitive Disorders (MG)
|
||
Completed |
NCT05525377 -
Better Living With Non-memory-led Dementia
|
N/A | |
Completed |
NCT02928848 -
Transcranial Direct Current Stimulation for Primary Progressive Aphasia
|
N/A | |
Completed |
NCT04939818 -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders
|